HALO vs MCO · P/E 15, rev $857.7M vs P/E 33, rev $4.26B
Halozyme Therapeutics Inc (HALO) versus Moodys Corporation (MCO) — a side-by-side from cached financials, not a winner call.
Halozyme Therapeutics Inc (HALO) is a biotechnology company listed on US.
Moodys Corporation (MCO) is a financial data & stock exchanges company listed on NYSE.
Latest reported HALO revenue for 2026-06-30 was $857.7M. Net income was $380.0M. HALO currently screens at market cap $7.10B and trailing P/E 15.3.
Latest reported MCO revenue for 2026-06-30 was $4.26B. Net income was $1.54B. MCO currently screens at market cap $79.69B and trailing P/E 32.7.
HALO currently screens at market cap $7.10B and trailing P/E 15.3. MCO currently screens at market cap $79.69B and trailing P/E 32.7.
Not investment advice. Open the HALO and MCO stock pages for the full models.
Not investment advice.